Tag Archives: Cost

Behavioral Chronic Migraine Treatment a Cost Effective Alternative

Behavioral chronic migraine treatment such as relaxation training, hypnosis and biofeedback makes financial sense in comparison to prescription medication, particularly after a year or longer. The costs of prescription medications, the type chronic migraine sufferers use on a daily basis in order to prevent onset, might not appear to be much even at a few… Read More »

MGMA to ONC: consider cost, complexity of compliance with new interoperability rules

The Medical Group Management Association is the latest industry group to offer feedback to the Office of the National Coordinator for Health IT and Centers for Medicare and Medicaid Services about their proposed interoperability rules. WHY IT MATTERSMGMA has big concerns about the cost, administrative burden the rules could put on physician practices, as well… Read More »

Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve

Industry watchers have been speculating for months about just how high Novartis would price gene therapy Zolgensma on approval—and just how payers would cover it. And with the FDA’s green light, they now have an answer. The Swiss drugmaker will roll out the drug, a one-time treatment for pediatric patients less than 2 years of… Read More »

Roche’s Tecentriq-Avastin lung cancer combo gets a lift from England’s cost watchdogs

Roche has some hard-earned knowledge about working with England’s cost watchdogs, especially where its cancer drugs are concerned. And it put that know-how to use to score backing for Tecentriq in lung cancer. The National Institute of Health and Care Excellence (NICE) decided to back the immuno-oncology drug, in combination with Roche’s Avastin and chemo,… Read More »